The impact of cerebrovascular disease
1Department of Neurology, LCI-7, Yale University School of Medicine, 15 York Street, Box 208018, New Haven, CT 06520, USA. lawrence.brass@yale.edu
Insights
Understanding stroke pathophysiology is key to prevention and treatment. This review highlights cerebrovascular disease, its impact on patients with diabetes, and cost-effective interventions.
Area of Science:
- Neurology
- Vascular Medicine
- Public Health
Background:
- Stroke is a leading cause of death and disability in the USA, with significant economic impact.
- Cerebrovascular disease underlies many strokes, involving conditions like atherosclerosis and coagulopathy.
- Patients with diabetes face elevated stroke risk and poorer outcomes, underscoring the need for targeted research.
Purpose of the Study:
- To review the pathophysiology of cerebrovascular disease and its link to stroke.
- To emphasize the heightened stroke risk and adverse outcomes in diabetic patients.
- To discuss interventions aimed at reducing stroke incidence and associated costs.
Main Methods:
- Literature review focusing on cerebrovascular disease and stroke.
- Analysis of the impact of underlying pathologic conditions on stroke.
- Examination of the economic burden and clinical outcomes related to stroke.
Main Results:
- Cerebrovascular disease is a major contributor to stroke morbidity and mortality.
- Diabetes exacerbates stroke risk and worsens patient prognosis.
- Effective interventions can decrease healthcare costs and improve patient outcomes.
Conclusions:
- A comprehensive understanding of stroke pathophysiology is crucial for effective management.
- Addressing cerebrovascular disease, especially in diabetic populations, is vital for public health.
- Reducing stroke incidence through targeted interventions offers significant economic and clinical benefits.
Abstract:
Stroke may be affected by pathologic conditions such as atherosclerosis, vascular injury, coagulopathy, and increased platelet aggregability. Knowledge of the pathophysiology of stroke is critical in order to effectively prevent or treat this disabling state. Cerebrovascular disease is the third leading cause of death in the USA. It is also associated with significant morbidity, leading to extremely high health care costs and lost productivity. Total estimated costs of stroke are estimated to be more than $45 billion annually. This is an especially important issue for patients with diabetes, who are at higher risk for stroke and have a worse clinical outcome than non-diabetic patients. This review describes the impact of vascular disease, particularly cerebrovascular disease, and describes the pathophysiology of the disease. Interventions that result in reduction of stroke will likely result in decreased health care costs and improved clinical outcomes.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Dementia l: Introduction


